Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue 3, 1998, Pages 210-220

  Beer, Brigitte ^a   Denner, Joachim ^a   Brown, Charles R ^b   Norley, Stephen ^a   Megede, Jan Zur ^a   Coulibaly, Cheik ^a   Plesker, Roland ^a   Holzammer, Silke ^a   Baier, Michael ^a   Hirsch, Vanessa M ^b   Kurth, Reinhard ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

African green monkeys; AIDS; CD4+ and CD8+ lymphocytes; Neonates; Pathogenesis; SIVagm; Virus load

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; HISTOPATHOLOGY; LYMPHOCYTE COUNT; MONKEY; MONONUCLEAR CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; TARGET CELL; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

ANIMALIA; CERCOPITHECUS AETHIOPS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 13144256714     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199807010-00003     Document Type: Article

References (45)

1. Kanki PJ, Kurth R, Becker W, Dreesman G, McLane MF, Essex M. Antibodies to simian T-lymphotropic retrovirus type III in African green monkeys and recognition of STLV-III viral proteins by AIDS and related sera. Lancet 1985;1:1330-2.
2. Hendry RM, Wells MA. Phelan MA, Schneider AL, Epstein JS, Quinnan GV. Antibodies to simian immunodeficiency virus in African green monkeys in Africa in 1957-62. Lancet 1986;2:455.
3. Ohta Y, Masuda T, Tsujimoto H, et al. Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates. Int J Cancer 1988;41:115-22.
4. Daniel MD, Li Y, Naidu YM, et al. Simian immunodeficiency virus from African green monkeys. J Virol 1988;62:4123-8.
5. Kraus G, Werner A, Baier M, et al. Isolation of human immunodeficiency virus-related simian immunodeficiency viruses from African green monkeys. Proc Natl Acad Sci USA 1989;86:2892-6.
6. Allan JS, Kanda P, Kennedy RC, Cobb EK, Anthony M, Eichberg JW. Isolation and characterization of simian immunodeficiency viruses from two subspecies of African green monkeys. AIDS Res Hum Retroviruses 1990;6:275-85.
7. Allan JS, Short M, Taylor ME, et al. Species-specific diversity among simian immunodeficiency viruses from African green monkeys. J Virol 1991;65:2816-28.
8. Mueller MC, Saksena NK, Nerrienet E, et al. Simian immunodeficiency viruses from central and western Africa: evidence for a new species-specific lentivirus in tantalus monkeys. J Virol 1993; 67:1227-35.
9. Johnson PR, Fomsgaard A, Allan JS, et al. Simian immunodeficiency viruses from African green monkeys display unusual genetic diversity. J Virol 1990;64:1086-92.
10. Fomsgaard A, Hirsch VM, Allan JS, Johnson PR. A highly divergent proviral DNA clone of SIV from a distinct species of African green monkey. Virology 1991;182:397-402.
11. Fukasawa M, Miura T, Hasegawa A, et al. Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group. Nature 1988;333:457-61.
12. Baier M, Garber C, Mueller C, Cichutek K, Kurth R. Complete nucleotide sequence of a simian immunodeficiency virus from African green monkeys: a novel type of intragroup divergence. Virology 1990;176:216-21.
13. Otsyula M, Yee J, Jennings M, et al. Prevalence of antibodies against simian immunodeficiency virus (SIV) and simian T-lymphotropic virus (STLV) in a colony of non-human primates in Kenya, East Africa. Ann Trop Med Parasitol 1996;90:65-70.
14. Kurth R, Norley S. Animal immunodeficiency viruses. In Levy JA, Weiss R, Neu HC, eds. Focus on HIV. Edinburgh: Churchill Livingstone, 1992.
15. Fefer A, McCoy JL, Glynn JP. Induction and regression of primary moloney sarcoma virus-induced tumors in mice. Cancer Res 1967; 27:1626-31.
16. Law LW, Ting RC, Stanton MF. Some biologic, immunogenic, and morphologic effects in mice after infection with a murine sarcoma virus. I. Biological and immunogenic studies. J Natl Cancer Inst 1968;40:1101-12.
17. Hoover EA, Olsen RG, Hardy WJ, Schaller JP, Mathes LE. Feline leukemia virus infection: age-related variation in response of cats to experimental infection. J Natl Cancer Inst 1976;57:365-9.
18. Tokunaga K, Shoda K, Nishino Y, et al. Maintenance of high virus load even after seroconversion in newborn cats acutely infected with feline immunodeficiency virus. Vaccine 1995;13:1393-8.
19. Galli L, de Martino MM, Tovo PA, et al. Onset of clinical signs in children with HIV-1 perinatal infection. Italian Register for HIV Infection in Children. AIDS 1995;9:455-61.
20. Wilfert CM, Wilson C, Luzuriaga K, Epstein L. Pathogenesis of pediatric human immunodeficiency virus type 1 infection. J Infect Dis 1994;170:286-92.
21. Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, Desrosiers RC. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992;258:1938-41.
22. Luciw PA, Mandell C. SIV vector expressing interleukin-2 for vaccination. Conf Adv Aids Vaccine Dev 1996;37:11-15.
23. Baba TW, Jeong YS, Pennick D, Bronson R, Greene MF. Ruprecht RM. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 1995;267:1820-5.
24. Otsyula MG, Gettie A, Suleman M, Tarara R, Mohamed I, Marx P. Apparent lack of vertical transmission of simian immunodeficiency virus (SIV) in naturally infected African green monkeys, Cercopithecus aethiops. Ann Trop Med Parasitol 1995;89:573-6.
25. Baier M, Werner A, Cichutek K, et al. Molecularly cloned simian immunodeficiency virus SIVagm3 is highly divergent from other SIVagm isolates and is biologically active in vitro and in vivo. J Virol 1989;63:5119-23.
26. Pyra H, Boeni J, Schuepbach J. Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc Natl Acad Sci USA 1994;91:1544-8.
27. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 1991;88:7276-80.
28. Beer B, Baier M, zur Megede J, Norley S, Kurth R. Vaccine effect using a live attenuated nef-deficient simian immunodeficiency virus of African green monkeys in the absence of detectable vaccine virus replication in vivo. Proc Natl Acad Sci USA 1997;94:4062-7.
29. Hirsch VM, Dapolito G, Johnson PR, et al. Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. J Virol 1995;69:955-67.
30. Norley SG, Kraus G, Ennen J, Bonilla J, König H, Kurth R. Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys. Proc Natl Acad Sci USA 1990;87:9067-71.
31. Beer B, Scherer J, zur Megede J, Norley S, Baier M, Kurth R. Lack of dichotomy between virus load of peripheral blood and lymph nodes during long-term simian immunodeficiency virus infection of African green monkeys. Virology 1996;219:367-75.
32. Beer B, Norley S, Kurth R. Simian immunodeficency virus infection of African green monkeys: a model for long-term nonprogression? J Acquir Immune Defic Syndr Hum Retrovirol 1997;15(Suppl 1):S34-9.
33. Kurth R, Norley S. Why don't the natural hosts of SIV develop simian AIDS? J Natl Inst Health Res 1996;8:33-37.
34. Hannet I, Erkeller YF, Lydyard P, Deneys V, DeBruyere M. Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol Today 1992;13:216-7.
35. Wiener D, Shah S, Malone J, Lowell N, Lowitt S, Rowlands DJ. Multiparametric analysis of peripheral blood in the normal pediatric population by flow cytometry. J Clin Lab Anal 1990;4:175-9.
36. + lymphocytes as prognostic markers of HIV-1 infection (see comments). Ann Intern Med 1997;126:946-54.
37. Calvelli TA, Rubinstein A. Pediatric HIV infection: a review. Immunodefic Rev 1990;2:83-127.
38. Reddy MM, Goetz RR, Gorman JM, Grieco MH, Chess L, Lederman S. Human immunodeficiency virus type-1 infection of homosexual men is accompanied by a decrease in circulating B cells. J Acquir Immune Defic Syndr 1991;4:428-34.
39. Blue ML, Daley JF, Levine H, Schlossman SF. Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry. J Immunol 1985;134:2281-6.
40. Tryphonas H, Lacroix F, Hayward S, Izaguirre C, Parenteau M, Fournier J. Cell surface marker evaluation of infant Macaca monkey leukocytes in peripheral whole blood using simultaneous dual-color immunophenotypic analysis. J Med Primatol 1996;25:89-105.
41. Ahmed-Ansari A, Brodie AR, Fultz PN, Anderson DC, Sell KW, McClure HM. Flow microfluorometric analysis of peripheral blood mononuclear cells from nonhuman primates: correlation of phenotype with immune function. Am J Primatol 1989;17:107-131.
42. Reimann KA, Waite BC, Lee PD, et al. Use of human leukocyte-specific monoclonal antibodies for clinically immunophenotyping lymphocytes of rhesus monkeys. Cytometry 1994;17:102-8.
43. Murayama Y, Amano A, Mukai R, et al. CD4 and CD8 expressions in African green monkey T lymphocytes: implication for resistance to SIV infection. Int Immunol 1997;9:843-51.
44. Wyand MS, Manson KH, Lackner AA, Desrosiers RC. Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus. Nature Med 1997;3:32-6.
45. Marthas ML, Van Rompay K, Otsyula M, et al. Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques. J Virol 1995;69:4198-4205.